The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first line therapy.
 
Deirdre Jill Cohen
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Guardant Health
Research Funding - Eisai (Inst); Merck (Inst); Viome (Inst)
 
Jonathan W Lee
No Relationships to Disclose
 
Daniel Jacob Becker
No Relationships to Disclose
 
Despina Siolas
Consulting or Advisory Role - Ciox Health; Zephyr AI
Speakers' Bureau - Natera
 
Nina Beri
No Relationships to Disclose
 
Theresa Ryan
Stock and Other Ownership Interests - AstraZeneca (I); Bristol-Myers Squibb/Roche; enzon (I); Pfizer (I)
Consulting or Advisory Role - Merck
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Bayer
 
Peter Kozuch
No Relationships to Disclose
 
Shun Yu
No Relationships to Disclose
 
Benjamin A. Levinson
No Relationships to Disclose
 
Judith D. Goldberg
Consulting or Advisory Role - Tizona Therapeutics, Inc.
Research Funding - assorted companies- see below
 
Lawrence P. Leichman
No Relationships to Disclose
 
Paul Eliezer Oberstein
Consulting or Advisory Role - Amal Therapeutics; Aravive; AstraZeneca; AstraZeneca; Merck; QED Therapeutics; Rubius Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Amal Therapeutics (Inst); Arcus Biosciences (Inst); Merck (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst); Zai Lab (Inst)
Expert Testimony - Ipsen
Travel, Accommodations, Expenses - Merck